233 related articles for article (PubMed ID: 26947964)
1. Efficacy and safety of sarolaner (Simparica™) against fleas on dogs presented as veterinary patients in the United States.
Cherni JA; Mahabir SP; Six RH
Vet Parasitol; 2016 May; 222():43-8. PubMed ID: 26947964
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™) in the treatment of naturally occurring flea and tick infestations in dogs presented as veterinary patients in Europe.
Becskei C; De Bock F; Illambas J; Mahabir SP; Farkas R; Six RH
Vet Parasitol; 2016 May; 222():49-55. PubMed ID: 26994516
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of sarolaner (Simparica
Packianathan R; Colgan S; Hodge A; Davis K; Six RH; Maeder S
Parasit Vectors; 2017 Aug; 10(1):387. PubMed ID: 28814332
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea infestations in client-owned dogs in the USA.
Kryda K; Mahabir SP; Inskeep T; Rugg J
Parasit Vectors; 2020 Mar; 13(1):98. PubMed ID: 32113472
[TBL] [Abstract][Full Text] [Related]
5. Comparative speed of kill of sarolaner (Simparica) and spinosad plus milbemycin oxime (Trifexis) against induced infestations of Ctenocephalides felis on dogs.
Six RH; Everett WR; Myers MR; Mahabir SP
Parasit Vectors; 2016 Feb; 9():93. PubMed ID: 26896448
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the speed of kill, effects on reproduction, and effectiveness in a simulated infested-home environment of sarolaner (Simparica™) against fleas on dogs.
Six RH; Becskei C; Carter L; Gale B; Young DR; Mahabir SP; Chapin S; Myers MR
Vet Parasitol; 2016 May; 222():23-7. PubMed ID: 26961589
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effectiveness of a novel oral formulation of sarolaner (Simparica™) for the treatment and control of fleas on dogs.
Six RH; Geurden T; Packianathan R; Colgan S; Everett WR; Grace S; Hodge A; Mahabir SP; Myers MR; Slootmans N; Davis K
Vet Parasitol; 2016 May; 222():18-22. PubMed ID: 26935820
[TBL] [Abstract][Full Text] [Related]
8. Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard) against induced infestations of Ctenocephalides felis on dogs.
Six RH; Liebenberg J; Honsberger NA; Mahabir SP
Parasit Vectors; 2016 Feb; 9():90. PubMed ID: 26896428
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA.
Karadzovska D; Chappell K; Coble S; Murphy M; Cavalleri D; Wiseman S; Drake J; Nanchen S
Parasit Vectors; 2017 Nov; 10(1):528. PubMed ID: 29089063
[TBL] [Abstract][Full Text] [Related]
10. Comparative speed of kill of sarolaner (Simparica and fluralaner (Bravecto) against induced infestations of Ctenocephalides felis on dogs.
Six RH; Liebenberg J; Honsberger NA; Mahabir SP
Parasit Vectors; 2016 Feb; 9():92. PubMed ID: 26896436
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a new spot-on formulation of selamectin plus sarolaner in the treatment of naturally occurring flea and tick infestations in cats presented as veterinary patients in Europe.
Geurden T; Becskei C; Farkas R; Lin D; Rugg D
Vet Parasitol; 2017 Apr; 238 Suppl 1():S12-S17. PubMed ID: 28395750
[TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™ CAT) in eliminating fleas in client-owned cats in the USA.
Chappell K; Paarlberg T; Seewald W; Karadzovska D; Nanchen S
Parasit Vectors; 2021 Mar; 14(1):127. PubMed ID: 33648556
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea and tick infestations on dogs presented as veterinary patients in Europe.
Becskei C; Fias D; Mahabir SP; Farkas R
Parasit Vectors; 2020 Mar; 13(1):72. PubMed ID: 32113486
[TBL] [Abstract][Full Text] [Related]
14. A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio™) in controlling fleas in client-owned dogs in European countries.
Cavalleri D; Murphy M; Seewald W; Drake J; Nanchen S
Parasit Vectors; 2017 Nov; 10(1):526. PubMed ID: 29089065
[TBL] [Abstract][Full Text] [Related]
15. Determination of the effective dose of a novel oral formulation of sarolaner (Simparica™) for the treatment and month-long control of fleas and ticks on dogs.
McTier TL; Six RH; Fourie JJ; Pullins A; Hedges L; Mahabir SP; Myers MR
Vet Parasitol; 2016 May; 222():12-7. PubMed ID: 26948830
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of sarolaner and spinosad oral treatments to eliminate fleas, reduce dermatologic lesions and minimize pruritus in naturally infested dogs in west Central Florida, USA.
Dryden MW; Canfield MS; Niedfeldt E; Kinnon A; Kalosy K; Smith A; Foley KM; Smith V; Bress TS; Smith N; Endrizzi M; Login J
Parasit Vectors; 2017 Aug; 10(1):389. PubMed ID: 28814316
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a combination of selamectin plus sarolaner for the treatment and prevention of flea infestations and the treatment of ear mites in cats presented as veterinary patients in the United States.
Vatta AF; Myers MR; Rugg JJ; Chapin S; Pullins A; King VL; Rugg D
Vet Parasitol; 2019 Jun; 270 Suppl 1():S3-S11. PubMed ID: 30579753
[TBL] [Abstract][Full Text] [Related]
18. A randomized, blinded, controlled USA field study to assess the use of fluralaner tablets in controlling canine flea infestations.
Meadows C; Guerino F; Sun F
Parasit Vectors; 2014 Aug; 7():375. PubMed ID: 25129395
[TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling fleas in client-owned cats in Europe.
Cavalleri D; Murphy M; Seewald W; Nanchen S
Parasit Vectors; 2018 Jul; 11(1):410. PubMed ID: 30001744
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a novel oral formulation of sarolaner (Simparica™) against four common tick species infesting dogs in Europe.
Geurden T; Becskei C; Grace S; Strube C; Doherty P; Liebenberg J; Mahabir SP; Slootmans N; Lloyd A; Six RH
Vet Parasitol; 2016 May; 222():33-6. PubMed ID: 27068640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
